Cytomegalovirus (CMV) Treatment Market Size, Trends, Share, Growth, and Opportunity Forecast, 2023 - 2030 Global Industry Analysis By Route of Administration (Oral, Topical, and Intravenous (IV)), By Treatment Approach (Solid Organ Transplantation, Stem Cell Transplantation, Antiviral Therapy, and Others), By End-User (Hospitals, Clinics, and Research Institute), By Sales Channel (Online Pharmacy Store, Retail Pharmacies, and Hospital Pharmacies) and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

By Route of Administration

·         Oral

·         Topical

·         Intravenous (IV)

By Treatment Approach

·         Solid Organ Transplantation

·         Stem Cell Transplantation

·         Antiviral Therapy

·         Others

By End-User

·         Hospitals

·         Clinics

·         Research Institute

By Sales Channel

·         Online Pharmacy Store

·         Retail Pharmacies

·         Hospital Pharmacies

By Geography

·         North America

·         Europe

·         Asia Pacific

·         South America

·         Middle East & Africa

Companies Profiled

·         Pfizer Inc.

·         F. Hoffmann-La Roche Ltd.

·         GSK plc

·         Thermo Fisher Scientific Inc.

·         Takeda Pharmaceutical Company Limited

·         Gilead Sciences, Inc.

·         Merck & Co., Inc.

·         Genentech, Inc.

·         Chimerix, Inc.

·         Clinigen Limited

·         Moderna, Inc.

·         Abbott

·         Bio-Rad Laboratories, Inc.

·         DiaSorin S.p.A.

·         Immucor Inc.

·         QIAGEN

·         AlphaVax

·         QuidelOrtho Corporation

·         altona Diagnostics GmbH

·         Trinity Biotech Plc

·         Others